In this study, we demonstrated that PMN-MDSCs derived from BPD infants had significantly weaker inhibitory effects on the proliferation of both CD4+ T and CD8+T cells than that derived from the non-BPD premature infants. This evidence concerns the gene CD8A and bronchopulmonary dysplasia.